Equities researchers at StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” ...

Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a ...

Amgen and AstraZeneca have reported outcomes from the WAYPOINT trial of Tezspire for treating chronic rhinosinusitis with ...

Conclusions: Our meta-analysis demonstrates that the addition of CDK4/6 inhibitors to endocrine therapy can result in improved PFS and OS for HR+ breast cancer patients. Meanwhile, we recommend close ...

Their new study identifies ... A New Way to Predict Cancer's Spread? Scientists Look at 'Stickiness' of Tumor Cells Mar. 5, 2025 — By assessing how 'sticky' tumor cells are, researchers have ...

When the Cancer moon connects with spontaneous Uranus on Sunday, you might make a new friend. There’s always room for one more! Or a group that you’ve wanted to join for a while might welcome ...

After hours: March 6 at 4:05:05 PM EST Loading Chart for PRLD ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.